Literature DB >> 6771823

Comparative enzyme-inducing effects of chlorpromazine and fluphenazine therapies in psychotic patients.

A W Harman, D B Frewin, B G Priestly.   

Abstract

Antipyrine elimination kinetics were measured in psychotic patients receiving either long-term chlorpromazine or fluphenazine decanoate therapy and in non-medicated control subjects. Patients receiving chlorpromazine metabolised antipyrine faster than the controls while, in patients receiving fluphenazine decanoate, there was not change. The results suggest that long-term chlorpromazine therapy induced the activity of drug-metabolising enzymes, whereas fluphenazine decanoate therapy had no effect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771823     DOI: 10.1007/bf00426518

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  The influence of barbiturates on coumarin plasma levels and prothrombin response.

Authors:  P G DAYTON; Y TARCAN; T CHENKIN; M WEINER
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

2.  Induction of increased meprobamate metabolism in rats pretreated with some neurotropic drugs.

Authors:  R KATO; P VASSANELLI
Journal:  Biochem Pharmacol       Date:  1962-08       Impact factor: 5.858

3.  The effect of fluphenazine decanoate (modecate) on hepatic microsomal enzyme activity in man.

Authors:  A N Latham; C Padgham; R Henryk-Gutt
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

Review 4.  Factors influencing antipyrine elimination.

Authors:  I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

5.  The effect of chlorpromazine on drug metabolism.

Authors:  I H Stevenson; K O'Malley; M J Turnbull; B R Ballinger
Journal:  J Pharm Pharmacol       Date:  1972-07       Impact factor: 3.765

6.  A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.

Authors:  A E Harman; B G Priestly; D B Frewin
Journal:  Clin Exp Pharmacol Physiol       Date:  1977 Nov-Dec       Impact factor: 2.557

7.  Increase of pentobarbitone metabolism induced in rats pretreated with some centrally acting compounds.

Authors:  R KATO; E CHIESARA
Journal:  Br J Pharmacol Chemother       Date:  1962-02

8.  Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

Authors:  S H Curry; R Whelpton; P J de Schepper; S Vranckx; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

9.  Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.

Authors:  A W Harman; R K Penhall; B G Priestly; D B Frewin; P J Phillips; A R Clarkson
Journal:  Aust N Z J Med       Date:  1977-08

10.  Disposition kinetics of spironolactone in hepatic failure after single doses and prolonged treatment.

Authors:  U Abshagen; H Rennekamp; G Luszpinski
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

View more
  1 in total

1.  Induction of microsomal enzyme activity by flupenthixol in chronic schizophrenics.

Authors:  S A Salem; D J King; D G McDevitt
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.